Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2014 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (410)	10/18/2014 7:16:06 AM
From: Robohogs	Respond to of 487

Just looked atmy contest entry for first time in long while. Must say my entry is completely at odds with medians. I am down moderately so way behind but my median pick is up moderately as my poor performance is due to crashers VVUS and GERN. 6 modest winners, 2 big losers and 2 modest losers. Interesting.

To: BulbaMan who wrote (410)	10/18/2014 7:59:05 AM
From: Robohogs	Read Replies (1) \| Respond to of 487

As much as I want to be out of the woods, I am nit sure we are. Resources sticks got KILLED on Friday and a chart of the IWM would suggest at least a potential retest of lows could be in irder. Might be just orofit taking in bith but violence of some of the moves and ersistence if small cap and biotech underperformance as day progressed has me thinking DOWN. And every time the QE has ended, mkts tank. I thought Europe QE might forestall this time but verdict is out. Jon PS. Heavy index shorts cost me so may be taling book.

To: BulbaMan who wrote (410)	11/1/2014 5:55:41 PM
From: BulbaMan	Read Replies (1) \| Respond to of 487

10/31/14 Contest update My flight landed at JFK almost simultaneously with news of the first Ebola case in New York. The doctor who contracted the virus had been riding the subways and wandering about the city for days prior to being diagnosed. Yet, aside from a few public officials, New Yorkers seemed to shrug off the appearance of a killer virus in their midst and I didn’t spot a single individual wearing a face mask. However, the story on Wall Street was different, with evident panic among the Bears as the market relentlessly climbed higher with no top in sight. At Friday’s close, the Contest median closed up 5.35% YTD (vs. up .57% YTD two weeks ago), while the larger-cap Nasdaq Biotech Index closed up an acrophobia-inducing 30.94% YTD (vs. up 17.12% YTD two weeks ago) and the Nasdaq Composite Index closed up 10.87% YTD (vs. up 1.96% YTD two weeks ago). Contest leader DIEGO’s portfolio rode the market wave, closing up 81.93% YTD. WATCHIT’s portfolio also had a good two weeks and moved into second place with a 72.26% YTD gain, with DEWDIL’s portfolio, up 68.59% YTD, slipping to third place. At Friday's close, 26 of the 46 Contest portfolios were in the black, while just 8 of the 46 beat the booming NBI. The median Contest portfolio stock (again SGEN) is down -8.07% YTD. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the two weeks. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None (All corrections, especially adjustments for splits, greatly appreciated.) Have a safe & relaxing weekend biotechies! And don’t forget, it’s “Fall Behind” on Sunday! Peace & good health, Bulba 10/31/14 Rank Name Profit/Loss 1 DIEGO 81,933 2 WATCHIT 72,258 3 DEWDIL 68,594 4 DOUGH 56,065 5 STEVEL 55,996 6 PGO 45,464 7 TECHNET 36,849 8 GHMM 31,139 9 ROCKY 30,537 10 JACKH 29,892 2 Week Top 5 Gainers Symbol 10/17 10/31 Wk.%chg. RGLS 6.63 19.96 201.06% ONCY 0.45 1.00 124.67% NVDQ 10.65 15.62 46.67% ESPR 21.53 29.25 35.86% INCY 50.08 67.06 33.91% 2 Week Worst 5 Losers Symbol 10/17 10/31 Wk.%chg. NSPH 0.73 0.44 -39.53% AEGR 31.01 20.19 -34.89% ADHD 5.40 3.62 -32.96% SRPT 22.22 16.17 -27.23% TKMR 21.76 16.68 -23.35%